Sort
10,766 grants matching “checkpoint inhibitor”
Repurposing systemic therapies to improve clinical outcomes in advanced basal cell cancer
$173,556Kavita Yang Sarin · Stanford University · K23 · FY2018 · CA
Characterization of Altered Immunity in Patients with Inflammatory Arthritis Induced by Immune Checkpoint Inhibitor Therapy
$173,556Sang Taek Kim · Yale University · K08 · FY2023 · AR
Repurposing systemic therapies to improve clinical outcomes in advanced basal cell cancer
$173,556Kavita Yang Sarin · Stanford University · K23 · FY2019 · CA
Repurposing systemic therapies to improve clinical outcomes in advanced basal cell cancer
$173,556Kavita Yang Sarin · Stanford University · K23 · FY2022 · CA
Repurposing systemic therapies to improve clinical outcomes in advanced basal cell cancer
$173,556Kavita Yang Sarin · Stanford University · K23 · FY2020 · CA
Repurposing systemic therapies to improve clinical outcomes in advanced basal cell cancer
$173,556Kavita Yang Sarin · Stanford University · K23 · FY2021 · CA
Characterization of Altered Immunity in Patients with Inflammatory Arthritis Induced by Immune Checkpoint Inhibitor Therapy
$173,556Sang Taek Kim · Yale University · K08 · FY2025 · AR
Characterization of Altered Immunity in Patients with Inflammatory Arthritis Induced by Immune Checkpoint Inhibitor Therapy
$173,556Sang Taek Kim · Yale University · K08 · FY2024 · AR
Elucidating mechanisms of checkpoint inhibitor-induced diabetes
$173,515Ana Luisa Jordao Perdigoto · Yale University · K08 · FY2023 · CA
Elucidating mechanisms of checkpoint inhibitor-induced diabetes
$173,515Ana Luisa Jordao Perdigoto · Yale University · K08 · FY2025 · CA
Elucidating mechanisms of checkpoint inhibitor-induced diabetes
$173,515Ana Luisa Jordao Perdigoto · Yale University · K08 · FY2024 · CA
Identifying the role of interferon and interferon-regulated chemokines in stress-induced immunosuppression in triple negative breast cancer
$173,500Shipra Gandhi · Roswell Park Cancer Institute Corp · R03 · FY2023 · TR
Development of Sapacitabine Therapy in Leukemias
$173,432William K Plunkett · University Of Tx Md Anderson Can Ctr · P50 · FY2008 · CA
STK11 loss of function and anti-PD-1 therapy resistance in KRAS-driven lung adenocarcinoma
$173,208David Joseph Seward · University Of Vermont & St Agric College · R21 · FY2024 · CA
Airway Immune Response in Critically Ill Children-Precision Medicine in Children At Risk for Acute Respiratory Distress Syndrome
$173,160Jocelyn Rebecca Grunwell · Emory University · K23 · FY2023 · HL
Therapeutic targeting of VHL-deficient clear cell renal cell carcinoma
$172,948Olga V Razorenova · University Of California-Irvine · R21 · FY2024 · CA
Unraveling the Role of PD-1 in CD8+ Tissue-Resident Memory T Cell Homeostasis and Epithelial Damage in Human Colitis
$172,800Molly Thomas · Oregon Health & Science University · K08 · FY2025 · DK
Unraveling the Role of PD-1 in CD8+ Tissue-Resident Memory T Cell Homeostasis and Epithelial Damage in Human Colitis
$172,800Molly Thomas · Massachusetts General Hospital · K08 · FY2023 · DK
Unraveling the Role of PD-1 in CD8+ Tissue-Resident Memory T Cell Homeostasis and Epithelial Damage in Human Colitis
$172,800Molly Thomas · Oregon Health & Science University · K08 · FY2024 · DK
(PQC1) PLK1 And EPHX3 Promotion Of Genomic Instability In Bronchial Dysplasia
$172,656Daniel Thomas Merrick · University Of Colorado Denver · R21 · FY2015 · CA
Impact of Obesity on Immuno-Oncology Agents in Endometrial Cancer
$172,653Victoria Lin Bae-Jump · Univ Of North Carolina Chapel Hill · R21 · FY2024 · CA
REGULATED PROTEOLYSIS AND LONG-TERM MEMORY
$172,593Wake Forest University Health Sciences · R01 · FY2000 · MH
Core 2: Glioblastoma Biorepository Core
$172,590Keith L Ligon · Brigham And Women'S Hospital · P01 · FY2021 · CA
Core 2: Glioblastoma Biorepository Core
$172,590Keith L Ligon · Brigham And Women'S Hospital · P01 · FY2020 · CA
Unraveling the Role of PD-1 in CD8+ Tissue-Resident Memory T Cell Homeostasis and Epithelial Damage in Human Colitis
$172,440Molly Thomas · Massachusetts General Hospital · K08 · FY2022 · DK